Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | TERN |
---|---|---|
09:32 ET | 9642 | 6.385 |
09:33 ET | 6570 | 6.245 |
09:35 ET | 5505 | 6.2 |
09:37 ET | 700 | 6.22 |
09:39 ET | 5984 | 6.15 |
09:42 ET | 250 | 6.1339 |
09:44 ET | 22815 | 6.1 |
09:46 ET | 4443 | 6.11 |
09:48 ET | 2873 | 6.15 |
09:50 ET | 7659 | 6.1598 |
09:51 ET | 400 | 6.13 |
09:53 ET | 18660 | 6.1 |
09:55 ET | 2521 | 6.15 |
09:57 ET | 1000 | 6.13 |
10:00 ET | 3694 | 6.115 |
10:02 ET | 7727 | 6.15 |
10:04 ET | 3853 | 6.1684 |
10:06 ET | 732 | 6.2 |
10:08 ET | 2003 | 6.19 |
10:09 ET | 2702 | 6.21 |
10:11 ET | 1290 | 6.21 |
10:13 ET | 3596 | 6.2097 |
10:15 ET | 5046 | 6.19 |
10:18 ET | 1533 | 6.19 |
10:20 ET | 500 | 6.15 |
10:22 ET | 6096 | 6.13 |
10:24 ET | 7156 | 6.145 |
10:26 ET | 7204 | 6.13 |
10:27 ET | 11876 | 6.08 |
10:29 ET | 700 | 6.081 |
10:31 ET | 2700 | 6.09 |
10:33 ET | 8691 | 6.08 |
10:36 ET | 300 | 6.07 |
10:38 ET | 900 | 6.04 |
10:40 ET | 7521 | 6.04 |
10:42 ET | 8237 | 6.065 |
10:44 ET | 4040 | 6.08 |
10:45 ET | 10754 | 6.1516 |
10:47 ET | 237 | 6.15 |
10:49 ET | 416 | 6.165 |
10:51 ET | 5047 | 6.21 |
10:54 ET | 5139 | 6.195 |
10:56 ET | 9303 | 6.16 |
10:58 ET | 300 | 6.15 |
11:00 ET | 1300 | 6.145 |
11:02 ET | 2100 | 6.17 |
11:03 ET | 200 | 6.17 |
11:05 ET | 2685 | 6.18 |
11:07 ET | 2000 | 6.17 |
11:09 ET | 4077 | 6.2 |
11:12 ET | 2305 | 6.21 |
11:14 ET | 4220 | 6.23 |
11:16 ET | 400 | 6.22 |
11:18 ET | 1100 | 6.21 |
11:20 ET | 600 | 6.2 |
11:21 ET | 952 | 6.2 |
11:23 ET | 331 | 6.21 |
11:25 ET | 1617 | 6.24 |
11:27 ET | 2800 | 6.21 |
11:30 ET | 341 | 6.215 |
11:32 ET | 2641 | 6.21 |
11:34 ET | 4376 | 6.22 |
11:36 ET | 3353 | 6.21 |
11:38 ET | 982 | 6.21 |
11:39 ET | 445 | 6.21 |
11:41 ET | 1274 | 6.22 |
11:43 ET | 5254 | 6.205 |
11:45 ET | 3342 | 6.2 |
11:48 ET | 790 | 6.2 |
11:50 ET | 300 | 6.2 |
11:52 ET | 6009 | 6.2101 |
11:54 ET | 5914 | 6.205 |
11:56 ET | 847 | 6.215 |
11:57 ET | 600 | 6.2 |
11:59 ET | 400 | 6.2 |
12:01 ET | 3381 | 6.2 |
12:03 ET | 8914 | 6.205 |
12:06 ET | 300 | 6.205 |
12:08 ET | 1378 | 6.2 |
12:10 ET | 1107 | 6.2 |
12:12 ET | 8885 | 6.209 |
12:14 ET | 12382 | 6.205 |
12:15 ET | 2585 | 6.2 |
12:17 ET | 19542 | 6.14 |
12:19 ET | 7465 | 6.165 |
12:21 ET | 3219 | 6.18 |
12:24 ET | 1206 | 6.165 |
12:26 ET | 1189 | 6.16 |
12:28 ET | 819 | 6.175 |
12:30 ET | 1586 | 6.175 |
12:32 ET | 1057 | 6.185 |
12:33 ET | 1578 | 6.19 |
12:35 ET | 1500 | 6.215 |
12:37 ET | 7159 | 6.17 |
12:39 ET | 3628 | 6.185 |
12:42 ET | 2200 | 6.185 |
12:44 ET | 2968 | 6.205 |
12:46 ET | 7706 | 6.205 |
12:48 ET | 2884 | 6.205 |
12:50 ET | 915 | 6.205 |
12:51 ET | 13321 | 6.245 |
12:53 ET | 14654 | 6.245 |
12:55 ET | 5198 | 6.225 |
12:57 ET | 6510 | 6.24 |
01:00 ET | 143208 | 6.24 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Terns Pharmaceuticals Inc | 499.4M | -5.3x | --- |
Kalvista Pharmaceuticals Inc | 495.2M | -2.8x | --- |
Alumis Inc | 511.4M | -2.0x | --- |
Korro Bio Inc | 515.2M | -3.1x | --- |
GH Research PLC | 482.8M | 0.0x | --- |
Opthea Ltd | 515.7M | -1.3x | --- |
Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Its pipeline includes three clinical-stage development programs: TERN-701, TERN-601 and TERN-501. TERN-701 is its oral, potent, allosteric BCR-ABL tyrosine kinase inhibitors (TKI) specifically targeting the ABL myristoyl pocket for CML, a form of cancer that begins in the bone marrow and leads to the growth of leukemic cells. TERN-601 is a small-molecule glucagon-like peptide-1 receptor (GLP-1R) agonist that is intended to be orally administered for obesity and other metabolic diseases. TERN-501 is a thyroid hormone receptor beta (THR-b) agonist with high metabolic stability and liver distribution. It is also focused on developing the TERN-800 series of small-molecule glucose-dependent insulinotropic polypeptide receptor (GIPR) modulators for obesity.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $499.4M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 84.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | -0.37 |
EPS | $-1.18 |
Book Value | $3.95 |
P/E Ratio | -5.3x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.